These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Cannabinoids and omega-3/6 endocannabinoids as cell death and anticancer modulators. Brown I; Cascio MG; Rotondo D; Pertwee RG; Heys SD; Wahle KW Prog Lipid Res; 2013 Jan; 52(1):80-109. PubMed ID: 23103355 [TBL] [Abstract][Full Text] [Related]
3. Therapeutic opportunities through modulation of the endocannabinoid system. Makriyannis A; Mechoulam R; Piomelli D Neuropharmacology; 2005 Jun; 48(8):1068-71. PubMed ID: 15885714 [No Abstract] [Full Text] [Related]
4. Cannabinoid drugs and enhancement of endocannabinoid responses: strategies for a wide array of disease states. Karanian DA; Bahr BA Curr Mol Med; 2006 Sep; 6(6):677-84. PubMed ID: 17022737 [TBL] [Abstract][Full Text] [Related]
6. Targeting the endocannabinoid system for the treatment of cancer--a practical view. Fowler CJ; Gustafsson SB; Chung SC; Persson E; Jacobsson SO; Bergh A Curr Top Med Chem; 2010; 10(8):814-27. PubMed ID: 20370711 [TBL] [Abstract][Full Text] [Related]
7. The endocannabinoid system and cancer: therapeutic implication. Guindon J; Hohmann AG Br J Pharmacol; 2011 Aug; 163(7):1447-63. PubMed ID: 21410463 [TBL] [Abstract][Full Text] [Related]
8. The Endocannabinoid System: A Target for Cancer Treatment. Laezza C; Pagano C; Navarra G; Pastorino O; Proto MC; Fiore D; Piscopo C; Gazzerro P; Bifulco M Int J Mol Sci; 2020 Jan; 21(3):. PubMed ID: 31979368 [TBL] [Abstract][Full Text] [Related]
9. The endocannabinoid system: physiology and pharmacology. Rodríguez de Fonseca F; Del Arco I; Bermudez-Silva FJ; Bilbao A; Cippitelli A; Navarro M Alcohol Alcohol; 2005; 40(1):2-14. PubMed ID: 15550444 [TBL] [Abstract][Full Text] [Related]
12. The therapeutic potential of drugs that target cannabinoid receptors or modulate the tissue levels or actions of endocannabinoids. Pertwee RG AAPS J; 2005 Oct; 7(3):E625-54. PubMed ID: 16353941 [TBL] [Abstract][Full Text] [Related]
13. The neuropharmacology of cannabinoid receptor ligands in central signaling pathways. Brunt TM; Bossong MG Eur J Neurosci; 2022 Feb; 55(4):909-921. PubMed ID: 32974975 [TBL] [Abstract][Full Text] [Related]
14. Cannabinoids as Prospective Anti-Cancer Drugs: Mechanism of Action in Healthy and Cancer Cells. Boyacıoğlu Ö; Korkusuz P Adv Exp Med Biol; 2023; 1410():145-169. PubMed ID: 36396926 [TBL] [Abstract][Full Text] [Related]
15. Cannabinoids and the gut: new developments and emerging concepts. Izzo AA; Sharkey KA Pharmacol Ther; 2010 Apr; 126(1):21-38. PubMed ID: 20117132 [TBL] [Abstract][Full Text] [Related]
17. Targeting the endocannabinoid system in treating brain disorders. Bahr BA; Karanian DA; Makanji SS; Makriyannis A Expert Opin Investig Drugs; 2006 Apr; 15(4):351-65. PubMed ID: 16548785 [TBL] [Abstract][Full Text] [Related]
18. Cannabinoid/Endocannabinoid signaling impact on early pregnancy events. Sun X; Dey SK Curr Top Behav Neurosci; 2009; 1():255-73. PubMed ID: 21104387 [TBL] [Abstract][Full Text] [Related]
19. Ligands for cannabinoid receptors, promising anticancer agents. Nikan M; Nabavi SM; Manayi A Life Sci; 2016 Feb; 146():124-30. PubMed ID: 26764235 [TBL] [Abstract][Full Text] [Related]
20. Endocannabinoid overactivity and intestinal inflammation. Di Marzo V; Izzo AA Gut; 2006 Oct; 55(10):1373-6. PubMed ID: 16966693 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]